TIPARP and differentiated thyroid carcinoma: TCGA data analyzed through XENA tools showed TIPARP mRNA was upregulated in male papillary thyroid carcinoma (PTC) with lymph node metastasis (LNM) versus without (AUC 0.692), indicating potential as a diagnostic biomarker (Fig. 3D).